Nina van der Hoeven

[Nina van der Hoeven @NWvanderHoeven]

@JEscaned @monaltiren @JACCJournals @ShamirMehta @NievesGonzalo1 @NielsRoyen Great research and clinically very relevant! Looking forward to work together on future projects @JEscaned

[PCRonline 🫀 @PCRonline]

Follow this exchange to learn how to detect, treat and follow a #MINOCA patient!

@NWvanderHoeven and @ColinBerryMD discuss the diagnostic approach of MINOCA:

📺https://t.co/oAcieLkr1q #EuroPCR #interventionalcardiology #cardiotwitter

[Mona Tirén @monaltiren]

#CoronaryPhysiology

#EuroPCR 2023
P U B L I C A T I O N

👋 Dr Lin Wang, Dr @JEscaned

Q F R vs F F R
NONCULPRIT S T E M I

From acute to subacute STEMI phase:

• FFR changes

• QFR no change

🤔

https://t.co/uaMzS3whAh

#ReduceMVI
#ACS
#MVD
#Microcirculation

[Petra Schlichtner @PSchlichtner]

Live from #EuroPCR … the many faces of #MINOCA
Interesting discussions from a stunning faculty about the role of intra coronary and non- invasive imaging
#CCTA #cMRI #OCT
It’s all about the right strategy for the right patient…

[Nina van der Hoeven @NWvanderHoeven]

@MGtberg @DavidLBrownMD @venkmurthy @SukhNijjer @lamelaspablo @ajaykirtane @GreggWStone @Guusdewaard @SVRaoMD @bnallamo @mmamas1973 @jerd10 @DrMarthaGulati @JEscaned @CCook_MD @DrJHoward @HeartFlow I totally agree

[Nina van der Hoeven @NWvanderHoeven]

Food for thought!

[JAMA Cardiology @JAMACardio]

Dr. @NWvanderhoeven: In the acute setting of #STEMI, nonculprit coronary flow reserve was reduced and FFR was augmented, whereas instantaneous wave-free ratio was not altered. https://t.co/mlatDFYUpR

[Nina van der Hoeven @NWvanderHoeven]

@venkmurthy Thank you for the interest in the paper @venkmurthy. To my opinion these data suggest to be careful with NC physiology measurements in patients with large infarcts and values around the cut-off. Perhaps a staged procedure in a more stable setting or a hybrid approach!

[Nina van der Hoeven @NWvanderHoeven]

@VerburghPastoor @volkskrant Dit lijkt me niet echt een gepaste opmerking

[CyclingOnline.nl @cyclingonlineNL]

De sprint voor de winst #DDO2019

[Nina van der Hoeven @NWvanderHoeven]

Proud of my baby! Let's hope this year is as good as last year :)

[Dorpenomloop Drenthe @DODrenthe]

De winnaar van vorig jaar @dbeukeboom tekent @DODrenthe #dod2019

[Nina van der Hoeven @NWvanderHoeven]

So proud of my colleague Jorrit Lemkes regarding his LBCT presentatie at ACC. Results of the COACT trial show a similar survival in immediate versus delayed angiography in post cardiac arrest patients! @NielsRoyen @amsterdamumc @ACCinTouch @MartyMleon @CMichaelGibson

[Nina van der Hoeven @NWvanderHoeven]

Just arrived in New Orleans to attend the ACC conference. Looking forward to hear the results of the largest new trials, and explore this great city!! @ACCinTouch

[Nina van der Hoeven @NWvanderHoeven]

Very interesting presentation by both @habib_samady and @jerd10 about physiology in ACS. Can we trust the FFR and iFR in non-culprit vessels in the acute setting of ACS? #optimizingpci #stfrancishospital #cardiology #NYC

[Nina van der Hoeven @NWvanderHoeven]

@NielsRoyen @VUmcAmsterdam

[Nina van der Hoeven @NWvanderHoeven]

Very proud of our group! We will present the results of the COACT trial as LBCT at the ACC '19, which will shed light on the optimal treatment of cardiac arrest patients without ST-elevation (immediate vs. late coronary angiography). @keaglemd @ACCinTouch @ACCmediacenter

[Nina van der Hoeven @NWvanderHoeven]

Great study in an unique dataset of patients with stable CAD who received PET imaging in our center. Results demonstrated that ''FFR, iFR, and Pd/Pa showed a similar performance when compared with PET imaging.''

@escardio @VUmcAmsterdam @Guusdewaard @NielsRoyen @TomLuscher

[Nina van der Hoeven @NWvanderHoeven]

Great manuscript written bij Michiel Bom from our center @VUmcAmsterdam !

[European Society of Cardiology Journals @ESC_Journals]

Diagnostic value of longitudinal flow gradient for the presence of haemodynamically significant coronary artery disease https://t.co/f4ZS8fgnBZ

@escardio @GeraldMaurer #EACVI #ESCCoT #CardioTwitter #freeaccess

[Nina van der Hoeven @NWvanderHoeven]

Another recently published great trial by van Leeuwen et al. compared the effect of ticagrelor and prasugrel maintenance therapy on reducing microvascular injury in STEMI patients. Very comprehensive and well executed study!

https://t.co/T3QOLWnPHR

@CircAHA @josephahill

[Nina van der Hoeven @NWvanderHoeven]

Great trial by Lemkes et al. recently published in EHJ.
They observed a similar small infarct size and MACE rate in transient STEMI patients treated with immediate versus delayed revascularization. @escardio @ESC_Journals @TomLuscher

https://t.co/XY8YIcVN2w

[Prof. Hector M. Garcia-Garcia @hect2701]

@hect2701 #TCT2018

“In STEMI, non-culprit hyperemic coronary hemodynamics
alter from index event to 1 month follow up as demonstrated
by an increased CFR, decreased resistance and decreased FFR.”

https://t.co/bKGCC7NK1w